Oakland, CA, United States of America

Liana M Klivansky

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Novartis Ag, Novartis Vaccines & Diagnostics, Gmbh. Active years: 2009-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liana M Klivansky. Retrieved from https://idiyas.com/inventor/liana-m-klivansky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0



Average Co-Inventor Count = 17.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2009-2014

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Liana M Klivansky

Introduction

Liana M Klivansky, based in Oakland, CA, is a distinguished inventor known for her groundbreaking work in the field of medicinal chemistry. With two patents to her name, her innovations have significantly contributed to the development of compounds used for therapeutic applications, particularly in the treatment of cancer and degenerative bone diseases.

Latest Patents

Klivansky's latest patents focus on 6-O-substituted benzoxazole and benzothiazole compounds. These patents disclose methods for inhibiting CSF-1R signaling through the development of benzoxazole and benzothiazole compounds, along with their stereoisomers, tautomers, solvates, oxides, esters, prodrugs, and pharmaceutically acceptable salts. The compositions that arise from these compounds can be used alone or in combination with additional therapeutic agents, showcasing their versatile applications. Specifically, these compounds are valuable in inhibiting cellular proliferation, preventing the growth and metastasis of tumors, and treating or preventing various conditions such as cancer and degenerative bone diseases, including rheumatoid arthritis.

Career Highlights

Klivansky has made her mark in prestigious organizations such as Novartis Vaccines & Diagnostics GmbH and Novartis AG. Her work in these companies has revolved around the development of therapeuticals aimed at addressing significant medical challenges, reinforcing her status as a leading figure in her field.

Collaborations

Throughout her career, Klivansky has collaborated with notable peers including James Clifford Sutton and Marion Wiesmann. These partnerships have played a crucial role in enhancing her research and expanding the reach of her innovative contributions to medicinal chemistry.

Conclusion

Liana M Klivansky exemplifies the spirit of innovation in the scientific community. With her focus on creating effective therapeutic agents, her patents not only underline her inventiveness but also offer significant promise in the fight against serious health conditions. Klivansky’s work sets the stage for future research and development in the pharmaceutical industry, paving the way for better treatments and improved patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…